Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Exercise × 30 days × Clear all

Sponsor

Conditions

Motor Activity 7 Breast Neoplasms 3 Obesity 2 Neoplasms 2 Sarcopenia 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphedema 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Anomia 1 Alzheimer Disease 1

Interventions

pembrolizumab 2 durvalumab 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1 cemiplimab 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡